Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Medtronic
Chubb
McKinsey
Merck

Generated: August 25, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207366

  Try a free trial


See Plans and Pricing

« Back to Dashboard

NDA 207366 describes RIBAVIRIN, which is a drug marketed by Aurobindo Pharma, Casi Pharms Inc, Teva, Zydus Pharms Usa, Navinta Llc, Beximco Pharms Usa, Heritage Pharma, Kadmon Pharms Llc, and Sandoz, and is included in eleven NDAs. It is available from eight suppliers. Additional details are available on the RIBAVIRIN profile page.

The generic ingredient in RIBAVIRIN is ribavirin. There are fifteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the ribavirin profile page.
Summary for 207366
Tradename:RIBAVIRIN
Applicant:Navinta Llc
Ingredient:ribavirin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 207366
Medical Subject Heading (MeSH) Categories for 207366
Suppliers and Packaging for NDA: 207366
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIBAVIRIN ribavirin FOR SOLUTION;INHALATION 207366 ANDA Zydus Pharmaceuticals USA Inc. 68382-395 68382-395-04 4 VIAL in 1 CARTON (68382-395-04) > 1 POWDER, FOR SOLUTION in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;INHALATIONStrength6GM/VIAL
Approval Date:Oct 6, 2016TE:ANRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Healthtrust
Chinese Patent Office
Federal Trade Commission
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.